Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: A 24-month study

Pediatric Dentistry

Volumn 33, Issue 2, 2011, Pages 165-170

  Erdem, Arzu Pinar ^a   Guven, Yeliz ^a   Balli, Beyza ^a   Ilhan, Banu ^a   Sepet, Elif ^a   Ulukapi, Isin ^a   Aktoren, Oya ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ferric Sulfate; Formocresol; MTA; Pulpotomy

Indexed keywords

ALUMINUM DERIVATIVE; BIOMEDICAL AND DENTAL MATERIALS; CALCIUM DERIVATIVE; DENTAL ALLOY; FERRIC ION; FERRIC SULFATE; FORMOCRESOL; MINERAL TRIOXIDE AGGREGATE; OXIDE; SILICATE; ZINC OXIDE EUGENOL;

ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECIDUOUS TOOTH; DENTAL CARIES; DENTAL SURGERY; DRUG COMBINATION; DRUG EFFECT; EDEMA; ENDODONTICS; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MOLAR TOOTH; PERIODONTAL DISEASE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TOOTH DISEASE; TOOTH FISTULA; TOOTH PAIN; TOOTH PERIAPICAL DISEASE; TREATMENT OUTCOME;

ALUMINUM COMPOUNDS; CALCIUM COMPOUNDS; CHILD; CHILD, PRESCHOOL; DENTAL AMALGAM; DENTAL CARIES; DENTAL FISTULA; DENTAL RESTORATION, PERMANENT; DRUG COMBINATIONS; EDEMA; FEMALE; FERRIC COMPOUNDS; FOLLOW-UP STUDIES; FORMOCRESOLS; FURCATION DEFECTS; HUMANS; MALE; MOLAR; OXIDES; PERIAPICAL DISEASES; PULP CAPPING AND PULPECTOMY AGENTS; PULPOTOMY; ROOT RESORPTION; SILICATES; SINGLE-BLIND METHOD; TOOTH MOBILITY; TOOTH, DECIDUOUS; TOOTHACHE; TREATMENT OUTCOME; ZINC OXIDE-EUGENOL CEMENT;

EID: 79958027330     PISSN: 01641263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fuks AB. Current concepts in vital primary pulp therapy. Eur J Paediatr Dent 2002;3:115-20.
2. Peng L, Ye L, Tan H, Zhou X. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: A meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:e40-4. (Pubitemid 44810056)
3. Rodd HD, Waterhouse PJ, Fuks AB, Fayle SA, Moffat MA. Pulp therapy for primary molars. UK National Clinical Guidelines in Paediatric Dentistry. Int J Paediatr Dent 2006;16(suppl 1):15-23.
4. American Academy of Paediatric Dentistry. Guideline on pulp therapy for primary and immature permanent teeth. Reference Manual 2009-10. Pediatr Dent 2009;31: 179-84.
5. Waterhouse PJ. "New age" pulp therapy: Personal thoughts on a hot debate. Pediatr Dent 2008;30:247-52.
6. Rodd HD, Boissonade FM. Immunocytochemical investigation of immune cells within human primary and permanent tooth pulp. Int J Paediatr Dent 2006;16:2-9. (Pubitemid 43455149)
7. Ranly DM, Garcia-Godoy F. Current and potential pulp therapies for primary and young permanent teeth. J Dent 2000;28:153-61.
8. Nadin G, Goel BR, Yeung CA, Glenny AM. Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev 2003;1:CD003220.
9. Farsi N, Alamoudi N, Balto K, Mushayt A. Success of mineral trioxide aggregate in pulpotomized primary molars. J Clin Pediatr Dent 2005;29:307-11. (Pubitemid 44152028)
10. Maroto M, Barbería E, Planells P, García Godoy F. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. Am J Dent 2005;18:151-4. (Pubitemid 41139533)
11. Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. Int Endod J 2007;40:261-7.
12. Sluyk SR, Moon PC, Hartwell GR. Evaluation of setting properties and retention characteristics of mineral trioxide aggregate when used as a furcation perforation repair material. J Endod 1998;24:768-71. (Pubitemid 128704288)
13. O'Sullivan SM, Hartwell GR. Obturation of a retained primary mandibular second molar using mineral trioxide aggregate: A case report. J Endod 2001;27:703-5. (Pubitemid 33753691)
14. Ng FK, Messer LB. Mineral trioxide aggregate as a pulpotomy medicament: An evidence-based assessment. Eur Arch Paediatr Dent 2008;9:58-73.
15. Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate vs formocresol in pulpotomized primary molars: A preliminary report. Pediatr Dent 2001;23:15-8. (Pubitemid 33699462)
16. Agamy HA, Bakry NS, Mounir MM, Avery DR. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent 2004;26:302-9. (Pubitemid 39277904)
17. Saltzman B, Sigal M, Clokie C, Rukavina J, Titley K, Kulkarni GV. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: Diode laser-mineral trioxide aggregate pulpotomy. Int J Paediatr Dent 2005;15:437-47. (Pubitemid 41551785)
18. Waterhouse PJ, Nunn JH, Whitworth JM, Soames JV. Primary molar pulp therapy: Histological evaluation of failure. Int J Paediatr Dent 2000;10:313-21.
19. Torabinejad M, Pitt Ford TR, McKendry DJ, Abedi HR, Miller DA, Kariyawasam SP. Histologic assessment of mineral trioxide aggregate as a root-end filling in monkeys. J Endod 1997;23:225-8. (Pubitemid 127730586)
20. Caicedo R, Abbott PV, Alongi DJ, Alarcon MY. Clinical, radiographic, and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth. Aust Dent J 2006;51: 297-305.
21. Lemon RR, Steele PJ, Jeansonne BG. Ferric sulfate hemostasis: Effect on osseous wound healing left in situ for maximum exposure. J Endod 1993;19:170-3.
22. Papagiannoulis L. Clinical studies on ferric sulphate as a pulpotomy medicament in primary teeth. Eur J Paediatr Dent 2002;3:126-32.
23. Ibricevic H, Al-Jame Q. Ferric sulphate and formocresol in pulpotomy of primary molars: Long-term follow-up study. Eur J Paediatr Dent 2003;4:28-32.
24. Smith NL, Seale NS, Nunn ME. Ferric sulfate pulpotomy in primary molars: A retrospective study. Pediatr Dent 2000;22:192-9.
25. Casas MJ, Kenny DJ, Johnston DH, Judd PL, Layug MA. Outcomes of vital primary incisor ferric sulfate pulpotomy and root canal therapy. J Can Dent Assoc 2004; 70:34-8. (Pubitemid 41080176)
26. Loh A, O'Hoy P, Tran X, et al. Evidence-based assessment: Evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatr Dent 2004;26:401-9. (Pubitemid 41742741)
27. Peng L, Ye L, Guo X, et al. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: A systematic review and meta-analysis. Int Endod J 2007;40: 751-7.
28. Huth KC, Paschos E, Hajek-Al-Khatar N, et al. Effectiveness of 4 pulpotomy techniques: A randomized controlled trial. J Dent Res 2005;84:1144-8. (Pubitemid 43827782)
29. Ng FK, Messer LB. Mineral trioxide aggregate as a pulpotomy medicament: A narrative review. Eur Arch Paediatr Dent 2008;9:4-11.
30. King SR, McWhorter AG, Seale NS. Concentration of formocresol used by pediatric dentists in primary tooth pulpotomy. Pediatr Dent 2002;24:157-9.
31. Rölling I, Thylstrup A. A 3-year clinical follow-up study of pulpotomized primary molars treated with the formocresol technique. Scand J Dent Res 1975;83:47-53.
32. Ranly DM. Pulpotomy therapy in primary teeth: New modalities for old rationales. Pediatr Dent 1994;16:403-9.
33. Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: Long-term follow up. Pediatr Dent 1997;19: 327-30. (Pubitemid 127735139)
34. Jabbarifar SE, Khademi AA, Gahsemi D. Success rate of formocresol pulpotomy versus mineral trioxide aggregate in human primary molar tooth. J Res Med Sci 2004;6: 304-7.
35. Moretti AB, Sakai VT, Oliveira TM, et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide, and formocresol for pulpotomies in primary teeth. Int Endod J 2008;41:547-55.
36. Holan G, Eidelman E, Fuks AB. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatr Dent 2005;27:129-36. (Pubitemid 43339749)
37. Willard RM. Radiographic changes following formocresol pulpotomy in primary molars. J Dent Child 1976; 43:414-5.
38. Tziafas D, Smith AJ, Lesot H. Designing new treatment strategies in vital pulp therapy. J Dent 2000;28:77-92.
39. Sonmez D, Sari S, Cetinba? T. A Comparison of four pulpotomy techniques in primary molars: A long-term follow-up. J Endod 2008;34:950-5.
40. Hunter ML. Premature exfoliation of primary molars related to the use of formocresol in a multivisit pulpotomy technique: A case report. Int J Paediatr Dent 2003; 13:362-4. (Pubitemid 37255667)
41. Vij R, Coll JA, Shelton P, Farooq NS. Caries control and other variables associated with success of primary molar vital pulp therapy. Pediatr Dent 2004;26:214-20. (Pubitemid 39273273)
42. Vargas KG, Packham B. Radiographic success of ferric sulfate and formocresol pulpotomies in relation to early exfoliation. Pediatr Dent 2005;27:233-7. (Pubitemid 43339739)
43. Croll TP, Killian CM. Zinc oxide-eugenol pulpotomy and stainless steel crown restoration of a primary molar. Quintessence Int 1992;23:383-8.
44. Holan G, Fuks AB, Ketlz N. Success rate of formocresol pulpotomy in primary molars restored with stainless steel crown vs amalgam. Pediatr Dent 2002;24:212-6.